InsiderTrades

Form 4 for ASTH Astrana Health, Inc.

Accepted 2026-02-03 00:00:00 ET · period of report 2026-02-02 · accession 0001104659-26-009940 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-02-03 2026-02-02 ASTH Sim Brandon CEO, Pres M - OptEx $23.24 +21.3K 1.05M +2% +$495.8K
D 2026-02-03 2026-02-02 ASTH Sim Brandon CEO, Pres M - OptEx $0.00 -21.3K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-02-02 M A 21,334 $23.24 1,045,329 D — — (F3) Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 29,919 shares, which will vest on June 27, 2026; and (ii) 51,309 shares, which will vest in three equal semi-annual installments, beginning March 31, 2026. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 75,433 restricted stock units, which will vest in five equal semi-annual installments beginning on April 2, 2026; and (ii) 127,437 restricted stock units, which will vest in seven equal semi-annual installments beginning on March 5, 2026. (F4) Includes 1,420 shares acquired under the Issuer's Employee Stock Purchase Plan.
2 Derivative Stock Option (right to buy) 2026-02-02 M D 21,334 $0.00 0 D $23.24 · — to 2026-02-02 21,334 Common Stock (F5) These stock options were fully vested and exercisable.